A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive…

Overview of attention for article published in BMC Infectious Diseases, October 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 113 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

PYRIDOSTIGMINE FOR USE IN THE TREATMENT OF COVID-19

Application WO-2022219372-A1

World Intellectual Property Organisation (WIPO)